About Digital Pathology Platforms
The Digital Pathology Platforms comprises 232 companies, including 108 funded companies having collectively raised $2.04B in venture capital money and private equity. Out of these, 52 are Series A+ funded.
Digital Pathology Platforms sector has seen 12 acquisitions and 4 IPOs. This represents almost 6.9% of all such companies - which is higher than the 4.2% exit rate of tech companies in general.
This sector includes companies providing digital pathology solutions for researchers.
Digital Pathology Platforms sector is also known as Computational Pathology Platforms.
Top Companies in Digital Pathology Platforms
There are more than 232 companies in Digital Pathology Platforms. PathAI is the top Digital Pathology Platforms company globally, ranked using Tracxn Score (what's this?).
Here are 5 of the top Digital Pathology Platforms companies globally:
Company | Description | Location | Founded | Current Stage | Private Funding Raised |
|---|---|---|---|---|---|
Provider of digital pathology image management system for clinical labs | Boston (United States) | 2016 | Series C | $255M | |
Provider of an AI and cloud-based, deep learning image analysis platform in all therapy areas | Helsinki (Finland) | 2014 | Public | $23M | |
Developer of artificial intelligence software for biomedical image analysis applications | Berlin (Germany) | 2018 | Series B | $53.9M | |
AI-assisted platform for image analysis | Chicago (United States) | 2017 | Series B | $60M | |
Artificial intelligence (AI) based image analysis platform for pathologists | Orem (United States) | 2014 | Series B | $50.4M |
Companies founded year-on-year in Digital Pathology Platforms
22 Digital Pathology Platforms startups were founded in 2019 - this is the most number of startups founded in any year in the last 10 years.
- Total Number of Companies
Year | No. of companies |
|---|---|
2026 | - |
2025 | 1 |
2024 | 6 |
2023 | 13 |
2022 | 12 |
2021 | 18 |
2020 | 19 |
2019 | 22 |
2018 | 16 |
2017 | 15 |
Companies founded across countries in Digital Pathology Platforms
United States has 86 Digital Pathology Platforms startups, the most by any country, followed by Germany which has 16 startups and United Kingdom which has 14.
- Total Number of Companies
Country | No. of companies |
|---|---|
United States | 86 |
Germany | 16 |
United Kingdom | 14 |
Canada | 15 |
India | 12 |
France | 10 |
China | 9 |
Netherlands | 6 |
South Korea | 5 |
Sweden | 5 |
Stage-wise distribution of Digital Pathology Platforms
Out of the total 232 Digital Pathology Platforms companies, 108 have secured funding. Among them, 52 have reached Series A or higher, and 36 to Series B or beyond.
Founded - 232
Funded - 108
Series A+ - 52
Series B+ - 36
Series C+ - 22
Company Stage | No. of companies |
|---|---|
Founded | 232 |
Funded | 108 |
Series A+ | 52 |
Series B+ | 36 |
Series C+ | 22 |
Want to know more about Digital Pathology Platforms ? Signup and explore Tracxn for free
- 230+ Total Companies
- $2.04B+ Total Funding
- 105+ Funded Companies
- 4 IPOs
- 10+ Acquisitions
Funding Trends in Digital Pathology Platforms
Total funding year-on-year in Digital Pathology Platforms
Digital Pathology Platforms saw a total funding of more than $1.82B in the last 10 years. The most amount of funding was in 2021 at more than $435M. There has been a total funding of $124M in 2026 till date.
- Total Funding
Year | Total Funding |
|---|---|
2026 | $124M |
2025 | $176M |
2024 | $145M |
2023 | $253M |
2022 | $227M |
2021 | $435M |
2020 | $129M |
2019 | $179M |
2018 | $89.1M |
2017 | $67.3M |
Total funding across countries in Digital Pathology Platforms
In the last 10 years, Digital Pathology Platforms startups in United States have recieved the highest funding among all countries - $1.38B. China follows with $168M and Germany with $94.3M.
- Total Funding
Country | Total Funding |
|---|---|
United States | $1.38B |
China | $168M |
Germany | $94.3M |
United Kingdom | $29.5M |
France | $19.3M |
Singapore | $14.4M |
Netherlands | $8.99M |
Japan | $8.8M |
Canada | $3.77M |
India | $3.56M |
Total funding amount raised by stage in Digital Pathology Platforms
Over the last 10 years, Digital Pathology Platforms have seen $86.4M into Seed Stage funding rounds, $1.13B into Early Stage funding rounds and $544M go into Late Stage funding rounds.
Funding Stage | Total Funding |
|---|---|
Early Stage | $1.13B |
Late Stage | $544M |
Seed Stage | $86.4M |
Grant | $47.9M |
Post IPO | $4.92M |
Recent Funding Rounds in Digital Pathology Platforms
In the year 2026, till June 2026, Digital Pathology Platforms companies have raised $124M in equity funding across 7 rounds.
In the same period last year (i.e. till May 2025), Digital Pathology Platforms companies had raised $141M across 7 rounds.
So, 2026 has seen a 11.73% drop in funding in Digital Pathology Platforms companies as compared to 2025.
Here are some recent, important funding rounds in Digital Pathology Platforms:
Company | Round Raised | Amount Raised | Funding Date | Investors |
|---|---|---|---|---|
Series D | 3029 | Jun 26, 2026 | ||
Series B | 4417 | Jun 17, 2026 | - | |
Series B | 2683 | Apr 30, 2026 | ||
Seed | 6392 | Apr 20, 2026 | ||
Series B | 6428 | Apr 14, 2026 |
Top Investors in Digital Pathology Platforms
Europa is the top investor in Digital Pathology Platforms companies based on number of companies invested.
Here are some top investors in Digital Pathology Platforms:
Investor | Location | Top Portfolio Companies |
|---|---|---|
Washington, DC (United States) | ||
Haidian (China) | ||
Burlington (United States) | ||
Bonn (Germany) |
M&A activity in Digital Pathology Platforms
In the year 2026, till May 2026, 2 acquisitions happened in Digital Pathology Platforms. Last year, in 2025, a total of 1 acquisition happened in Digital Pathology Platforms.
Here are some recent, important acquisitions in Digital Pathology Platforms:
Company | Acquisition Type | Acquisition Date | Acquirers |
|---|---|---|---|
Business Acquisition | May 21, 2026 | ||
Business Acquisition | Jan 13, 2026 | ||
Business Acquisition | Aug 22, 2025 | ||
Business Acquisition | Feb 06, 2024 | ||
Business Acquisition | 2020 |
Acquisition trends in Digital Pathology Platforms
Here are the acquisition trends in Digital Pathology Platforms:
- Total Number of Acquisitions
Year | No. of companies |
|---|---|
2026 | 2 |
2025 | 1 |
2024 | 1 |
2023 | - |
2022 | - |
2021 | - |
2020 | 1 |
2019 | - |
2018 | 1 |
2017 | 1 |
IPOs in Digital Pathology Platforms
In the year 2021, till December 2021, 1 IPO happened in Digital Pathology Platforms.
Here are some recent, important IPOs in Digital Pathology Platforms:
Company | IPO Date | Exchange Symbol |
|---|---|---|
Dec 10, 2021 | Helsinki Exchange (HEL) | |
Mar 21, 1986 | Toronto Stock Exchange - Venture Exchange (TSX-V) |
Colleges which produce the most Digital Pathology Platforms companies
Companies founded by alumni from top colleges in Digital Pathology Platforms
Most number of Digital Pathology Platforms startups have been founded by alumni from Stanford University, Massachusetts Institute of Technology and University of Toronto.
College | No. of companies |
|---|---|
Stanford University | 8 |
Massachusetts Institute of Technology | 4 |
University of Toronto | 4 |
Harvard University | 3 |
BITS Pilani | 2 |
ETH Zurich | 2 |
Imperial College London | 2 |
Indian Institute Of Management–Lucknow | 2 |
University College London | 2 |
Aalto University | 1 |
Total funding in companies founded by alumni from top colleges in the Digital Pathology Platforms
In the last 10 years, Stanford University graduates' Digital Pathology Platforms companies have raised the most funding among top colleges. Massachusetts Institute of Technology alumni are second, and ETH Zurich alumni are third.
College | Total Funding |
|---|---|
Stanford University | $362M |
Massachusetts Institute of Technology | $319M |
ETH Zurich | $241M |
University of California (Los Angeles) | $123M |
University of Cambridge | $123M |
University of Toronto | $65.7M |
Technion Israel Institute Technology | $58.5M |
INSEAD | $55.4M |
Technische Universität Berlin | $55.4M |
Harvard University | $43.2M |
Top News in Digital Pathology Platforms
•
Mopec Expands Partnership with Lumea for Digital Pathology IntegrationPR Newswire•Sep 28, 2025•Mopec, Lumea
•
•
•
B-rayZ Partners with Affidea, Secures Investment to Enhance Breast Cancer DiagnosticsStartupticker•Jun 30, 2025•b-rayZ, Affidea
•
Affidea Group Chooses b-rayZ as Preferred AI Partner for Breast Imaging in Strategic PartnershipGlobeNewswire•Jun 30, 2025•Affidea, b-rayZ
•
•
•
Nucleai's AI speeds drug discovery by automating spatial proteomics analysis.
Business Wire•Apr 22, 2025•Nucle AI
•
Pathai Expands Aisight® Digital Pathology Adoption With Four New Laboratory PartnersGlobeNewswire•Mar 24, 2025•PathAI, Annapath, Peninsula Pathologists, Pathology Group Of Louisiana and 1 other
•
Techcyte Unveils Fusion, the First Unified Anatomic and Clinical Digital Pathology PlatformBusiness Wire•Mar 24, 2025•Techcyte
